Research indicates that dexamethasone, a pre-hydroxylated, synthetic, active form of GC, can enhance gluconeogenesis in mouse HCC by promoting the expression of PEPCK, G6Pase, and FBP1. Here, PCK2 is linked to hepatocellular carcinoma.